{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:40:35Z","timestamp":1792197635727,"version":"4.4.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10787-026-02342-y","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:47:38Z","timestamp":1788533258000},"page":"6487-6517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting cytokine-driven neuroinflammation in Alzheimer\u2019s disease: mechanistic insights and pharmacological strategies"],"prefix":"10.1007","volume":"34","author":[{"given":"Rufaida","family":"Wasim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"3","key":"2342_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WST, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie I, Wyss-Coray T (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21(3):383\u2013421","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2342_CR4","first-page":"17","volume":"2","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE et al (2025) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Neuroglia 2(2):17","journal-title":"Neuroglia"},{"issue":"11","key":"2342_CR6","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, K\u00fcgler S, Ikezu T (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18(11):1584\u20131593","journal-title":"Nat Neurosci"},{"issue":"4","key":"2342_CR7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jamaneurol.2023.0050","volume":"80","author":"NJ Ashton","year":"2023","unstructured":"Ashton NJ, Moseby-Knappe M, Benedet AL, Gr\u00f6tschel L, Lantero-Rodriguez J, Karikari TK, Hassager C, Wise MP, Stammet P, Kjaergaard J, Friberg H (2023) Alzheimer disease blood biomarkers in patients with out-of-hospital cardiac arrest. JAMA Neurol 80(4):388\u2013396","journal-title":"JAMA Neurol"},{"issue":"6","key":"2342_CR10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1523\/JNEUROSCI.3516-14.2015","volume":"35","author":"L Ben Haim","year":"2015","unstructured":"Ben Haim L, Ceyz\u00e9riat K, Carrillo-de Sauvage MA, Aubry F, Auregan G, Guillermier M et al (2015) The JAK\/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer\u2019s and Huntington\u2019s diseases. J Neurosci 35(6):2817\u20132829","journal-title":"J Neurosci"},{"issue":"4","key":"2342_CR11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/clpt.2014.147","volume":"96","author":"BM Bettcher","year":"2014","unstructured":"Bettcher BM, Kramer JH (2014) Longitudinal inflammation, cognitive decline, and Alzheimer\u2019s disease: a mini-review. Clin Pharmacol Ther 96(4):464\u2013469","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2342_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2342_CR14","first-page":"903","volume":"29","author":"P Boss\u00f9","year":"2008","unstructured":"Boss\u00f9 P, Ciaramella A, Salani F, Bizzoni F, Varsi E, Di Iulio F et al (2008) Interleukin-18 produced by peripheral blood cells is increased in Alzheimer\u2019s disease. Neurobiol Aging 29(6):903\u2013907","journal-title":"Neurobiol Aging"},{"issue":"7","key":"2342_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","volume":"16","author":"EM Bradshaw","year":"2013","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A, Alzheimer Disease Neuroimaging Initiative (2013) CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16(7):848\u2013850","journal-title":"Nat Neurosci"},{"issue":"4","key":"2342_CR16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JCS Breitner","year":"2011","unstructured":"Breitner JCS, Baker LD, Montine TJ et al (2011) Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimers Dement 7(4):402\u2013411","journal-title":"Alzheimers Dement"},{"issue":"6","key":"2342_CR17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P (2016) Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement 12(6):719\u2013732","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2342_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50\u201383","journal-title":"Microbiol Mol Biol Rev"},{"key":"2342_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK (2014) Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 11:98","journal-title":"J Neuroinflammation"},{"key":"2342_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2342_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","volume":"4","author":"CA Colton","year":"2009","unstructured":"Colton CA (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4(4):399\u2013418","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"2342_CR23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jalz.2018.05.006","volume":"15","author":"J Cummings","year":"2019","unstructured":"Cummings J (2019) The National institute on aging\u2014Alzheimer\u2019s association framework on Alzheimer\u2019s disease: application to clinical trials. Alzheimers Dement 15(1):172\u2013178","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2342_CR24","volume":"10","author":"J Cummings","year":"2024","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2024) Alzheimer\u2019s disease drug development pipeline: 2024. Alzheimer\u2019s Dement Transl Res Clin Interv 10(2):e12465","journal-title":"Alzheimer's Dement Transl Res Clin Interv"},{"issue":"7717","key":"2342_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, Contarino C, Onengut-Gumuscu S, Farber E, Raper D, Viar KE (2018) Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature 560(7717):185\u2013191","journal-title":"Nature"},{"key":"2342_CR26","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/s41593-024-01791-4","volume":"27","author":"S Das","year":"2024","unstructured":"Das S et al (2024) Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer\u2019s disease. Nat Neurosci 27:2384\u20132400","journal-title":"Nat Neurosci"},{"issue":"4","key":"2342_CR27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The cellular phase of Alzheimer\u2019s disease. Cell 164(4):603\u2013615","journal-title":"Cell"},{"issue":"2","key":"2342_CR28","first-page":"i","volume":"2008","author":"P Deane","year":"2008","unstructured":"Deane P, Odendahl N, Quinlan T, Fowles M, Welsh C, Bivens\u2010Tatum J (2008) Cognitive models of writing: writing proficiency as a complex integrated skill. ETS Res Rep Ser 2008(2):i\u201336","journal-title":"ETS Res Rep Ser"},{"issue":"4","key":"2342_CR29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1567205013666160930110551","volume":"14","author":"B Decourt","year":"2017","unstructured":"Decourt B, Lahiri DK, Sabbagh MN (2017) Targeting tumor necrosis factor alpha for Alzheimer\u2019s disease. Curr Alzheimer Res 14(4):412\u2013425","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"2342_CR30","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I (2018) Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173(5):1073\u20131081","journal-title":"Cell"},{"issue":"2","key":"2342_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-023-00983-6","volume":"24","author":"A Deczkowska","year":"2024","unstructured":"Deczkowska A, Weiner A, Amit I (2024) TREM2, microglia, and neurodegeneration: emerging mechanisms and therapeutic opportunities. Nat Rev Immunol 24(2):85\u2013101","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2342_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA (2018) Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 281(1):8\u201327","journal-title":"Immunol Rev"},{"issue":"2","key":"2342_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2017","unstructured":"Drummond E, Wisniewski T (2017) Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol 133(2):155\u2013175","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2342_CR35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","volume":"33","author":"B Engelhardt","year":"2012","unstructured":"Engelhardt B, Ransohoff RM (2012) Capture, crawl, cross: the T cell code to breach the blood\u2013brain barriers. Trends Immunol 33(12):579\u2013589","journal-title":"Trends Immunol"},{"issue":"5","key":"2342_CR36","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","volume":"61","author":"MJ Engelhart","year":"2004","unstructured":"Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, Van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61(5):668\u2013672","journal-title":"Arch Neurol"},{"issue":"10","key":"2342_CR37","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33(10):1500\u20131513","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"2342_CR38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(03)00684-6","volume":"40","author":"JL Eriksen","year":"2003","unstructured":"Eriksen JL, Dawson TM, Dickson DW, Petrucelli L (2003) Caught in the act: \u03b1-synuclein is the culprit in Parkinson\u2019s disease. Neuron 40(3):453\u2013456","journal-title":"Neuron"},{"issue":"10","key":"2342_CR39","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1113\/jphysiol.2012.246082","volume":"591","author":"D Farina","year":"2013","unstructured":"Farina D, Negro F, Jiang N (2013) Identification of common synaptic inputs to motor neurons from the rectified electromyogram. J Physiol 591(10):2403\u20132418","journal-title":"J Physiol"},{"issue":"5","key":"2342_CR40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0301-0082(97)00021-X","volume":"52","author":"RA Gadient","year":"1997","unstructured":"Gadient RA, Otten UH (1997) Interleukin-6 (IL-6): a molecule with both beneficial and destructive potentials. Prog Neurobiol 52(5):379\u2013390","journal-title":"Prog Neurobiol"},{"issue":"7790","key":"2342_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D et al (2020) Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577(7790):399\u2013404","journal-title":"Nature"},{"key":"2342_CR42","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","volume":"109","author":"S Ghosh","year":"2002","unstructured":"Ghosh S, Karin M (2002) Missing pieces in the NF-\u03baB puzzle. Cell 109:S81\u2013S96","journal-title":"Cell"},{"issue":"6","key":"2342_CR43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934","journal-title":"Cell"},{"issue":"8","key":"2342_CR44","first-page":"2150","volume":"20","author":"Y Gong","year":"2025","unstructured":"Gong Y et al (2025) Research developments in the neurovascular unit and Alzheimer\u2019s disease. Neural Regen Res 20(8):2150\u20132162","journal-title":"Neural Regen Res"},{"issue":"3","key":"2342_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF02740665","volume":"15","author":"DL Gruol","year":"1997","unstructured":"Gruol DL, Nelson TE (1997) Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 15(3):307\u2013339","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2342_CR47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","volume":"85","author":"MV Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J, Leung BP, Rezai-Zadeh K, Town T (2015) IL-10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85(3):534\u2013548","journal-title":"Neuron"},{"key":"2342_CR49","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS et al (2024) APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature 628:154\u2013161","journal-title":"Nature"},{"issue":"2","key":"2342_CR50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217(2):459\u2013472","journal-title":"J Cell Biol"},{"issue":"2","key":"2342_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/cr.2011.13","volume":"21","author":"MS Hayden","year":"2012","unstructured":"Hayden MS, Ghosh S (2012) NF-\u03baB in immunobiology. Cell Res 21(2):223\u2013244","journal-title":"Cell Res"},{"key":"2342_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E (2014) Innate immune activation in neurodegenerative disease. Nat Rev Immunol 14:463\u2013477","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2342_CR53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth G, Brosseron F, Feinstein D, Jacobs A, Wyss-Coray T, Vitorica J, Ransohoff R, Herrup K, Frautschy S, Finsen B, Brown G, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405","journal-title":"Lancet Neurol"},{"issue":"6","key":"2342_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358\u2013372","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"2342_CR55","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359\u20131369","journal-title":"Nat Neurosci"},{"issue":"S1","key":"2342_CR56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/16506070902980729","volume":"38","author":"EA Holmes","year":"2009","unstructured":"Holmes EA, Lang TJ, Deeprose C (2009) Mental imagery and emotion in treatment across disorders: Using the example of depression. Cogn Behav Ther 38(S1):21\u201328","journal-title":"Cogn Behav Ther"},{"issue":"6286","key":"2342_CR57","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352(6286):712\u2013716","journal-title":"Science"},{"key":"2342_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-026-02211-8","author":"KN Ibrahim","year":"2026","unstructured":"Ibrahim KN, Wasim R, Rahman E (2026) HMGB1-mediated neuroinflammation: molecular mechanisms and emerging therapeutic approaches. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-026-02211-8","journal-title":"Inflammopharmacology"},{"key":"2342_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41419-017-0153-x","volume":"9","author":"C Ising","year":"2018","unstructured":"Ising C, Heneka MT (2018) Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration. Cell Death Dis 9:120","journal-title":"Cell Death Dis"},{"issue":"7784","key":"2342_CR61","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673","journal-title":"Nature"},{"issue":"4","key":"2342_CR62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14(4):535\u2013562","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2342_CR63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116","journal-title":"N Engl J Med"},{"key":"2342_CR64","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.94.6.2642","volume":"94","author":"B Kaltschmidt","year":"1997","unstructured":"Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C (1997) Inhibition of NF-\u03baB potentiates amyloid \u03b2-mediated neuronal apoptosis. Proc Natl Acad Sci U S A 94:2642\u20132647","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2342_CR65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbamcr.2005.05.009","volume":"1745","author":"B Kaltschmidt","year":"2005","unstructured":"Kaltschmidt B, Widera D, Kaltschmidt C (2005) Signaling via NF-\u03baB in the nervous system. Biochimica Et Biophysica Acta (BBA)-Mol Cell Res 1745(3):287\u2013299","journal-title":"Biochimica Et Biophysica Acta (BBA)-Mol Cell Res"},{"key":"2342_CR66","doi-asserted-by":"crossref","first-page":"1491952","DOI":"10.3389\/fncel.2024.1491952","volume":"18","author":"D Kempuraj","year":"2024","unstructured":"Kempuraj D et al (2024) Neurovascular unit, neuroinflammation and neurodegeneration. Front Cell Neurosci 18:1491952","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"2342_CR67","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169(7):1276\u20131290","journal-title":"Cell"},{"key":"2342_CR68","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","volume":"89","author":"EK Kim","year":"2015","unstructured":"Kim EK, Choi EJ (2015) Compromised MAPK signaling in human diseases. Arch Toxicol 89:867\u2013882","journal-title":"Arch Toxicol"},{"key":"2342_CR69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimers Dement Transl Res Clin Interv 4:575\u2013590","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"7","key":"2342_CR70","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/gt.2011.126","volume":"19","author":"T Kiyota","year":"2012","unstructured":"Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, Ikezu TA (2012) AAV serotype 2\/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+ PS1 mice. Gene Ther 19(7):724\u2013733","journal-title":"Gene Ther"},{"issue":"7","key":"2342_CR71","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"JH Lee","year":"2010","unstructured":"Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141(7):1146\u20131158","journal-title":"Cell"},{"issue":"3","key":"2342_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2342_CR73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","volume":"16","author":"JJ Letterio","year":"1998","unstructured":"Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-\u03b2. Annu Rev Immunol 16(1):137\u2013161","journal-title":"Annu Rev Immunol"},{"key":"2342_CR74","first-page":"123","volume":"27","author":"Q Li","year":"2024","unstructured":"Li Q, Barres BA et al (2024) Emerging roles of anti-inflammatory cytokines in neurodegenerative diseases. Nat Neurosci 27:123\u2013134","journal-title":"Nat Neurosci"},{"key":"2342_CR75","doi-asserted-by":"crossref","first-page":"1583886","DOI":"10.3389\/fimmu.2025.1583886","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z et al (2025) NLRP3 inflammasome in Alzheimer\u2019s disease. Front Immunol 16:1583886","journal-title":"Front Immunol"},{"key":"2342_CR76","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0197-4580(00)00163-9","volume":"21","author":"F Licastro","year":"2000","unstructured":"Licastro F, Pedrini S, Caputo L, Annoni G, Davis L, Ferri C, Casadei V (2000) Increased plasma levels of IL-6 in Alzheimer\u2019s disease. Neurobiol Aging 21:613\u2013616","journal-title":"Neurobiol Aging"},{"key":"2342_CR77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-023-01372-w","volume":"16","author":"A Liu","year":"2024","unstructured":"Liu A, Fernandes BS, Zhao Z et al (2024) Unraveling the intercellular communication disruption and key pathways in Alzheimer\u2019s disease: an integrative study of single-nucleus transcriptomes and genetic association. Alzheimers Res Ther 16:3","journal-title":"Alzheimers Res Ther"},{"key":"2342_CR78","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Costafreda S et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413\u2013446","journal-title":"Lancet"},{"issue":"1","key":"2342_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12974-016-0763-8","volume":"13","author":"D Lobo-Silva","year":"2016","unstructured":"Lobo-Silva D, Carriche GM, Castro AG, Roque S, Saraiva M (2016) Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation 13(1):297","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2342_CR80","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339","journal-title":"Cell"},{"issue":"3","key":"2342_CR81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.exger.2006.09.015","volume":"42","author":"S Magaki","year":"2007","unstructured":"Magaki S, Mueller C, Dickson C, Kirsch W (2007) Increased production of inflammatory cytokines in mild cognitive impairment. Exp Gerontol 42(3):233\u2013240","journal-title":"Exp Gerontol"},{"issue":"3","key":"2342_CR82","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Camandola S (2001) NF-\u03baB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107(3):247\u2013254","journal-title":"J Clin Invest"},{"key":"2342_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1742-2094-5-45","volume":"5","author":"MK McCoy","year":"2008","unstructured":"McCoy MK, Tansey MG (2008) TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 5:45","journal-title":"J Neuroinflammation"},{"issue":"10","key":"2342_CR84","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2165\/00023210-200721100-00001","volume":"21","author":"EG McGeer","year":"2007","unstructured":"McGeer EG, McGeer PL (2007) The role of anti-inflammatory agents in Parkinson\u2019s disease. CNS Drugs 21(10):789\u2013797","journal-title":"CNS Drugs"},{"issue":"4","key":"2342_CR85","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","volume":"126","author":"PL McGeer","year":"2013","unstructured":"McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease. Acta Neuropathol 126(4):479\u2013497","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2342_CR86","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/biom15050676","volume":"15","author":"J McGroarty","year":"2025","unstructured":"McGroarty J et al (2025) Inflammasome-mediated neuroinflammation: a key driver in Alzheimer\u2019s disease. Biomolecules 15(5):676","journal-title":"Biomolecules"},{"issue":"5","key":"2342_CR87","first-page":"289","volume":"20","author":"RM McManus","year":"2024","unstructured":"McManus RM, Latz E, Heneka MT (2024) NLRP3 inflammasome signalling in Alzheimer\u2019s disease. Nat Rev Neurol 20(5):289\u2013305","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"2342_CR88","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","volume":"136","author":"GP Morris","year":"2018","unstructured":"Morris GP, Clark IA, Vissel B (2018) Questions concerning the role of amyloid-\u03b2 in the definition, aetiology and diagnosis of Alzheimer\u2019s disease. Acta Neuropathol 136(5):663\u2013689","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2342_CR89","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","volume":"58","author":"L Munoz","year":"2010","unstructured":"Munoz L, Ammit AJ (2010) Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease. Neuropharmacology 58(3):561\u2013568","journal-title":"Neuropharmacology"},{"issue":"4","key":"2342_CR90","first-page":"1021","volume":"32","author":"S Musunuri","year":"2024","unstructured":"Musunuri S et al (2024) Gene therapy approaches for neurodegenerative diseases. Mol Ther 32(4):1021\u20131038","journal-title":"Mol Ther"},{"issue":"12","key":"2342_CR92","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM (2013) Development, maintenance and disruption of the blood-brain barrier. Nat Med 19(12):1584\u20131596","journal-title":"Nat Med"},{"issue":"1","key":"2342_CR93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O'Bryant","year":"2017","unstructured":"O\u2019Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H et al (2017) Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 13(1):45\u201358","journal-title":"Alzheimers Dement"},{"issue":"7","key":"2342_CR94","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15(7):673\u2013684","journal-title":"Lancet Neurol"},{"key":"2342_CR95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O'Shea","year":"2015","unstructured":"O\u2019Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66:311\u2013328","journal-title":"Annu Rev Med"},{"issue":"35","key":"2342_CR96","volume":"121","author":"LL Owen","year":"2024","unstructured":"Owen LL, Manning JR (2024) High-level cognition is supported by information-rich but compressible brain activity patterns. Proc Natl Acad Sci 121(35):e2400082121","journal-title":"Proc Natl Acad Sci"},{"key":"2342_CR97","doi-asserted-by":"crossref","first-page":"1459134","DOI":"10.3389\/fnagi.2024.1459134","volume":"16","author":"I Paesmans","year":"2024","unstructured":"Paesmans I, Van Hoecke L, Lamkanfi M et al (2024) Inflammasome activation and pyroptosis as therapeutic targets in Alzheimer\u2019s disease. Front Aging Neurosci 16:1459134","journal-title":"Front Aging Neurosci"},{"key":"2342_CR98","first-page":"112","volume":"381","author":"M Patel","year":"2025","unstructured":"Patel M et al (2025) Blood-brain barrier-targeted nanomedicine for neurodegenerative diseases. J Control Release 381:112\u2013128","journal-title":"J Control Release"},{"issue":"2","key":"2342_CR99","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/antiox13020240","volume":"13","author":"C Peggion","year":"2024","unstructured":"Peggion C et al (2024) Mitochondrial dysfunction and neuroinflammation in neurodegenerative diseases. Antioxidants (Basel) 13(2):240","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"2342_CR100","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrn3722","volume":"15","author":"M Prinz","year":"2014","unstructured":"Prinz M, Priller J (2014) Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 15(5):300\u2013312","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"2342_CR101","first-page":"31","volume":"54","author":"P Qin","year":"2024","unstructured":"Qin P et al (2024) Mitochondrial dysfunction in chronic neuroinflammatory diseases. Int J Mol Med 54(2):31","journal-title":"Int J Mol Med"},{"issue":"6301","key":"2342_CR102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM (2016) How neuroinflammation contributes to neurodegeneration. Science 353(6301):777\u2013783","journal-title":"Science"},{"issue":"16","key":"2342_CR103","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","volume":"353","author":"T Rhen","year":"2005","unstructured":"Rhen T, Cidlowski JA (2005) Antiinflammatory action of glucocorticoids: new mechanisms for old drugs. N Engl J Med 353(16):1711\u20131723","journal-title":"N Engl J Med"},{"issue":"9","key":"2342_CR104","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med 23(9):1018\u20131027","journal-title":"Nat Med"},{"issue":"3","key":"2342_CR105","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","volume":"10","author":"M Saraiva","year":"2010","unstructured":"Saraiva M, O\u2019Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10(3):170\u2013181","journal-title":"Nat Rev Immunol"},{"key":"2342_CR106","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"C Saraiva","year":"2016","unstructured":"Saraiva C, Pra\u00e7a C, Ferreira R, Santos T, Ferreira L, Bernardino L (2016) Nanoparticle-mediated brain drug delivery. J Control Release 235:34\u201347","journal-title":"J Control Release"},{"key":"2342_CR107","volume":"208","author":"C Saraiva","year":"2024","unstructured":"Saraiva C et al (2024) Nanoparticle-mediated delivery strategies for central nervous system disorders. Adv Drug Deliv Rev 208:115207","journal-title":"Adv Drug Deliv Rev"},{"issue":"17","key":"2342_CR108","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H et al (2017) APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J 36(17):2473\u20132487","journal-title":"EMBO J"},{"issue":"5","key":"2342_CR109","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1813(5):878\u2013888","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"2342_CR110","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C, Cummings J, van der Flier W (2021) Alzheimer\u2019s disease. Lancet 397:1577\u20131590","journal-title":"Lancet"},{"issue":"10","key":"2342_CR111","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","volume":"37","author":"M Schwartz","year":"2016","unstructured":"Schwartz M, Deczkowska A (2016) Neurological disease as a failure of brain\u2013immune crosstalk: the multiple faces of neuroinflammation. Trends Immunol 37(10):668\u2013679","journal-title":"Trends Immunol"},{"issue":"6","key":"2342_CR112","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8(6):595\u2013608","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2342_CR113","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"8","key":"2342_CR114","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM (2008) Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14(8):837\u2013842","journal-title":"Nat Med"},{"issue":"4","key":"2342_CR115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","volume":"49","author":"AR Simard","year":"2006","unstructured":"Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease. Neuron 49(4):489\u2013502","journal-title":"Neuron"},{"issue":"5","key":"2342_CR116","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/a-2052-8462","volume":"55","author":"A Singh","year":"2023","unstructured":"Singh A, Ansari VA, Ansari TM, Hasan SM, Ahsan F, Singh K et al (2023) Consequence of dementia and cognitive impairment by primary nucleation pathway. Horm Metab Res 55(5):304\u2013314","journal-title":"Horm Metab Res"},{"issue":"5","key":"2342_CR117","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrn3898","volume":"16","author":"MV Sofroniew","year":"2015","unstructured":"Sofroniew MV (2015) Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci 16(5):249\u2013263","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2342_CR118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","volume":"119","author":"MV Sofroniew","year":"2010","unstructured":"Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119(1):7\u201335","journal-title":"Acta Neuropathol"},{"issue":"7087","key":"2342_CR119","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/nature04671","volume":"440","author":"D Stellwagen","year":"2006","unstructured":"Stellwagen D, Malenka RC (2006) Synaptic scaling mediated by glial TNF-\u03b1. Nature 440(7087):1054\u20131059","journal-title":"Nature"},{"issue":"1","key":"2342_CR120","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","volume":"16","author":"V Sudhakar","year":"2019","unstructured":"Sudhakar V, Richardson RM (2019) Gene therapy for neurodegenerative diseases. Neurotherapeutics 16(1):166\u2013175","journal-title":"Neurotherapeutics"},{"issue":"10","key":"2342_CR121","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L, Wong A, Cappell J, Herrmann N (2010) A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry 68(10):930\u2013941","journal-title":"Biol Psychiatry"},{"issue":"3","key":"2342_CR122","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2342_CR123","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2019) Blood-brain barrier breakdown in Alzheimer disease. Nat Rev Neurol 15(3):133\u2013150","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"2342_CR124","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","volume":"74","author":"E Tarkowski","year":"2003","unstructured":"Tarkowski E, Andreasen N, Tarkowski A, Blennow K (2003) Intrathecal inflammation precedes development of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 74(9):1200\u20131205","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2342_CR125","first-page":"22","volume":"26","author":"J Tcw","year":"2025","unstructured":"Tcw J, Goate AM (2025) Precision genomic therapies in Alzheimer\u2019s disease. Nat Rev Genet 26(1):22\u201340","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2342_CR126","first-page":"572","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol off J American Neurol Assoc Child Neurol Soc 30(4):572\u2013580","journal-title":"Ann Neurol off J American Neurol Assoc Child Neurol Soc"},{"issue":"1","key":"2342_CR127","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IM, Thijssen EH, Vermunt L, Hansson O, Zetterberg H et al (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21(1):66\u201377","journal-title":"Lancet Neurol"},{"key":"2342_CR128","first-page":"178","volume":"9","author":"E Tobinick","year":"2012","unstructured":"Tobinick E, Gross H, Weinberger A, Cohen H (2012) TNF-alpha modulation for treatment of Alzheimer\u2019s disease. J Neuroinflammation 9:178","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2342_CR129","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/NMM:7:3:255","volume":"7","author":"T Town","year":"2005","unstructured":"Town T, Tan J, Flavell RA, Mullan M (2005) T-cells in Alzheimer\u2019s disease. Neuromol Med 7(3):255\u2013264","journal-title":"Neuromol Med"},{"issue":"11","key":"2342_CR130","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M (2018) TREM2\u2014a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 14(11):667\u2013675","journal-title":"Nat Rev Neurol"},{"key":"2342_CR132","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0140-6736(17)30492-0","volume":"389","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Liljeroth M, Cramer S, Stuart C, Zotova E, Darekar A et al (2017) Systemic inflammation and blood\u2013brain barrier abnormality in relapsing\u2013remitting multiple sclerosis. Lancet 389:S96","journal-title":"Lancet"},{"issue":"7","key":"2342_CR133","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a035188","volume":"11","author":"A Verkhratsky","year":"2019","unstructured":"Verkhratsky A (2019) Astroglial calcium signaling in aging and Alzheimer\u2019s disease. Cold Spring Harb Perspect Biol 11(7):a035188","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2342_CR134","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98(1):239\u2013389","journal-title":"Physiol Rev"},{"issue":"6","key":"2342_CR135","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.mp.4000813","volume":"5","author":"L Vitkovic","year":"2000","unstructured":"Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, Jacque C (2000) Cytokine signals propagate through the brain. Mol Psychiatry 5(6):604\u2013615","journal-title":"Mol Psychiatry"},{"issue":"19","key":"2342_CR136","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad SC, Miller DR, Kowall NW, Felson DT (2008) Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70(19):1672\u20131677","journal-title":"Neurology"},{"issue":"9","key":"2342_CR137","first-page":"455","volume":"26","author":"V Waetzig","year":"2005","unstructured":"Waetzig V, Herdegen T (2005) Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharmacol Sci 26(9):455\u2013461","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2342_CR138","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17(1):5\u201321","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2342_CR139","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"185","author":"Y Wang","year":"2022","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML et al (2022) TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 185(6):1061\u20131071","journal-title":"Cell"},{"issue":"1","key":"2342_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49790-0","volume":"15","author":"Q Wang","year":"2024","unstructured":"Wang Q, Antone J, Alsop E, Reiman R, Funk C, Bendl J, Dudley JT, Liang WS, Karr TL, Roussos P, Bennett DA (2024a) Single cell transcriptomes and multiscale networks from persons with and without Alzheimer\u2019s disease. Nat Commun 15(1):5815","journal-title":"Nat Commun"},{"key":"2342_CR141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13195-024-01575-9","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang S et al (2024b) TREM2-mediated microglial regulation in Alzheimer\u2019s disease. Alzheimers Res Ther 16:211","journal-title":"Alzheimers Res Ther"},{"key":"2342_CR142","doi-asserted-by":"crossref","first-page":"1484373","DOI":"10.3389\/fimmu.2024.1484373","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025) Mitochondrial dysfunction in Alzheimer\u2019s disease: a key contributor to neurodegeneration. Front Immunol 16:1484373","journal-title":"Front Immunol"},{"key":"2342_CR143","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13024-026-00947-z","volume":"21","author":"L Wang","year":"2026","unstructured":"Wang L et al (2026) Dysfunction of the neurovascular unit as a temporal driver in Alzheimer\u2019s disease. Mol Neurodegener 21:48","journal-title":"Mol Neurodegener"},{"issue":"9","key":"2342_CR144","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s10787-025-01916-6","volume":"33","author":"R Wasim","year":"2025","unstructured":"Wasim R (2025) Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer\u2019s disease. Inflammopharmacology 33(9):5273\u20135289","journal-title":"Inflammopharmacology"},{"key":"2342_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2026.178986","author":"R Wasim","year":"2026","unstructured":"Wasim R (2026) Nitric Oxide Signaling in Alzheimer\u2019s Disease: A Double-Edged Sword. Eur J Pharmacol. pp 178986. https:\/\/doi.org\/10.1016\/j.ejphar.2026.178986","journal-title":"Eur J Pharmacol"},{"key":"2342_CR146","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/9789815238754124010011","volume-title":"Advances in diagnostics and immunotherapeutics for neurodegenerative diseases","author":"R Wasim","year":"2024","unstructured":"Wasim R, Mahmood T, Ahsan F, Singh A, Ahmad A (2024) Epigenetics as diagnostic and therapeutic tool in neurodegenerative disorders. Advances in diagnostics and immunotherapeutics for neurodegenerative diseases. Bentham Science Publishers, pp 162\u2013176"},{"issue":"1","key":"2342_CR148","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030525","volume":"7","author":"K Westin","year":"2012","unstructured":"Westin K, Buchhave P, Nielsen H, Minthon L, Janciauskiene S, Hansson O (2012) CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer\u2019s disease. PLoS ONE 7(1):e30525","journal-title":"PLoS ONE"},{"key":"2342_CR149","first-page":"421","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu W et al (2025) NLRP3 inflammasome in neuroinflammation and central nervous system disorders. Cell Mol Immunol 22:421\u2013438","journal-title":"Cell Mol Immunol"},{"key":"2342_CR150","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-024-01453-w","volume":"44","author":"W Yu","year":"2024","unstructured":"Yu W, Li Y, Zhong F et al (2024) Disease-associated neurotoxic astrocyte markers in Alzheimer disease based on integrative single-nucleus RNA sequencing. Cell Mol Neurobiol 44:20","journal-title":"Cell Mol Neurobiol"},{"key":"2342_CR152","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-024-00445-0","volume":"21","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Yang G, Luo Y et al (2024) Neuroinflammation in Alzheimer\u2019s disease: insights from peripheral immune cells. Immun Ageing 21:38","journal-title":"Immun Ageing"},{"issue":"1","key":"2342_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-150","volume":"8","author":"J Zhao","year":"2011","unstructured":"Zhao J, O\u2019Connor T, Vassar R (2011) The contribution of activated astrocytes to A\u03b2 production: implications for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 8(1):150","journal-title":"J Neuroinflammation"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02342-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02342-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02342-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:55:39Z","timestamp":1792194939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02342-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":138,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2342"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02342-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have given their consent for publication of the manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}